These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17353632)

  • 21. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions.
    Forni C; Ferrari S; Loro L; Mazzei T; Beghelli C; Biolchini A; Simoni P; Tremosini M; Strazzari S; Puggioli C; Bacci G
    Support Care Cancer; 2000 Mar; 8(2):131-3. PubMed ID: 10739360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of granisetron rescue therapy for nausea and vomiting induced by cancer chemotherapies in urogenital malignant tumor].
    Takigawa H; Naruo S; Kanayama H; Kagawa S; Yokoseki H; Inai T; Sumitani H; Sakurai N; Ogawa I; Akazawa S
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):899-903. PubMed ID: 8678539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey].
    Debrix I; Puteaux S; Milleron B; Becker A
    Ann Pharm Fr; 1995; 53(4):170-5. PubMed ID: 7574271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
    Takahashi T; Mori K; Suga Y; Tominaga K
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
    Feng F; Zhang P; He Y; Li Y; Zhou M; Chen G; Li L
    Chin Med Sci J; 2002 Sep; 17(3):168-72. PubMed ID: 12901541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
    Ishioka S; Sagae S; Saito T; Kiya T; Sugimura M; Akutagawa N; Umemura K; Ito E; Kudo R
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):593-8. PubMed ID: 10791002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].
    Taguchi T; Tsukamoto F; Watanabe T; Yoneda K; Takamura Y; Hojo S; Shiba E; Noguchi S
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1163-70. PubMed ID: 10431583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new antiemetic ramosetron hydrochloride].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):371-80. PubMed ID: 9051143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
    Nakayama S; Torii Y; Noda T
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1121-7. PubMed ID: 11525029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
    Constenla M
    Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
    Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
    Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A randomized crossover study of ramosetron plus dexamethasone for the prevention of nausea and vomiting induced by chemotherapy including cisplatin-comparison of ramosetron combined with 8 mg and 12 mg of dexamethasone].
    Tanigaki Y; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Yoshida T; Ishitoya J; Katori H; Ikeda Y; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2091-5. PubMed ID: 16352934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Jpn J Clin Oncol; 2009 Feb; 39(2):111-5. PubMed ID: 19060294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
    Hisano C; Nakano S; Okuma K; Masumoto N; Fujishima H; Nakamura M; Niho Y
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1175-81. PubMed ID: 8751806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer.
    Morita M; Kuwano H; Ohno S; Kitamura K; Sugimachi K
    Anticancer Res; 2000; 20(5C):3631-6. PubMed ID: 11268430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.